Cisplatin is an essential chemotherapy medication used to treat several cancers including testicular, ovarian, cervical and bladder as well as brain tumours. JM was instrumental in the development of Cisplatin; manufacturing it at our facility in West Whiteland, Pennsylvania since 1978.
CAS number: 15663-27-1
Our Controlled Substance and API portfolio is supported by a global network of GMP facilities: West Deptford, NJ; Devens, MA; North Andover, MA; Edinburgh, UK and Annan, UK.
USP, Ph. Eur., JP *
* Monographs are available on request
† Regulatory filings are available on request